Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study

被引:74
|
作者
Jakimovski, D. [1 ]
Gandhi, S. [1 ]
Paunkoski, I. [1 ]
Bergsland, N. [1 ]
Hagemeier, J. [1 ]
Ramasamy, D. P. [1 ]
Hojnacki, D. [2 ]
Kolb, C. [2 ]
Benedict, R. H. B. [2 ]
Weinstock-Guttman, B. [2 ]
Zivadinov, R. [1 ,3 ]
机构
[1] SUNY Buffalo, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo Neuroimaging Anal Ctr, Buffalo, NY USA
[2] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Jacobs Comprehens MS Treatment & Res Ctr, Buffalo, NY USA
[3] SUNY Buffalo, Clin Translat Sci Inst, Ctr Biomed Imaging, Buffalo, NY USA
基金
美国国家卫生研究院;
关键词
brain atrophy; heart disease; hypertension; lateral ventricular volume; MRI; multiple sclerosis; LIPID PROFILE; SMOKING; COMORBIDITY; PROGRESSION; DISABILITY; INCREASES; VOLUMES; DELAYS; RISK;
D O I
10.1111/ene.13769
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Cardiovascular diseases (CVDs) are more frequent in multiple sclerosis (MS) patients when compared to controls. In particular, CVDs are linked with higher accumulation of lesions and advanced brain atrophy. Objective To investigate whether CVDs contribute to accelerated lesion accumulation and brain atrophy over 5 years in patients with MS. Methods 194 MS patients and 43 controls without neurologic disease were followed for 5 years. Full physical, neurological evaluation, and structured questionnaire investigating CVD and risk factors (hypertension, hyperlipidemia, heart disease, smoking, diabetes, obesity/overweight) were collected using interview-based questionnaire and further cross-reference with electronic medical records. Lesion and brain atrophy outcomes were assessed with 3T MRI. ANCOVA adjusted for age, gender, and disease duration were used accordingly. False discovery rate correction was performed using Benjamini-Hochberg correction. Results Patients with diagnosis of heart disease showed higher white matter and whole brain volume loss compared to those without (-4.2% vs. -0.7%, P = 0.01 and -3.4% vs. -1.6%, P = 0.01, respectively). The percentage lateral ventricle volume change in MS patients with hypertension was higher compared to non-hypertensive patients (24.5% vs. 14.1%, P = 0.05). Hyperlipidemia, smoking, and obesity/overweight were not associated with progression of MRI-derived outcomes. CVDs did not contribute to larger lesion volume accrual over the 5-year period. The presence of CVDs was not associated with MRI-derived changes in the controls. Conclusions Hypertension and heart disease contribute to advanced brain atrophy in MS patients. CVDs did not contribute to additional lesion accrual. CVD comorbidities in MS patients may contribute to neurodegenerative tissue injury that can be detected with brain MRI.
引用
收藏
页码:87 / +
页数:8
相关论文
共 50 条
  • [41] Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study
    Fuchs, T. A.
    Carolus, K.
    Benedict, R. H. B.
    Bergsland, N.
    Ramasamy, D.
    Jakimovski, D.
    Weinstock-Guttman, B.
    Kuceyeski, A.
    Zivadinov, R.
    Dwyer, M. G.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (08) : 1480 - 1486
  • [42] Periodontitis and hypertension are linked through systemic inflammation: A 5-year longitudinal study
    Torrungruang, Kitti
    Vathesatogkit, Prin
    Mahanonda, Rangsini
    Thienpramuk, Lalitsara
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2024, 51 (05) : 536 - 546
  • [43] Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study
    Azzimonti, Matteo
    Preziosa, Paolo
    Pagani, Elisabetta
    Valsasina, Paola
    Tedone, Nicolo
    Vizzino, Carmen
    Rocca, Maria A. A.
    Filippi, Massimo
    JOURNAL OF NEUROLOGY, 2023, 270 (09) : 4296 - 4308
  • [44] Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis
    Molenaar, Pam C. G.
    Noteboom, Samantha
    van Nederpelt, David R.
    Krijnen, Eva A.
    Jelgerhuis, Julia R.
    Lam, Ka-Hoo
    Druijff-van de Woestijne, Gerrieke B.
    Meijer, Kim A.
    van Oirschot, Pim
    de Jong, Brigit A.
    Brouwer, Iman
    Jasperse, Bas
    de Groot, Vincent
    Uitdehaag, Bernard M. J.
    Schoonheim, Menno M.
    Strijbis, Eva M. M.
    Killestein, Joep
    JOURNAL OF NEUROLOGY, 2024, : 5958 - 5968
  • [45] Hypertension and 5-Year Mortality among 85-Year-Olds: The Jerusalem Longitudinal Study
    Jacobs, Jeremy M.
    Stessman, Jochanan
    Ein-Mor, Eliana
    Bursztyn, Michael
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2012, 13 (08) : 759.e1 - 759.e6
  • [46] Can glatiramer acetate reduce brain atrophy development in multiple sclerosis?
    Rovaris, M
    Comi, G
    Filippi, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 233 (1-2) : 139 - 143
  • [47] Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study
    Stevenson, VL
    Ingle, GT
    Miller, DH
    Thompson, AJ
    MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (04) : 398 - 401
  • [48] Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis
    Radue, Ernst Wilhelm
    Bendfeldt, Kerstin
    Mueller-Lenke, Nicole
    Magon, Stefano
    Sprenger, Till
    SWISS MEDICAL WEEKLY, 2013, 143
  • [49] Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
    Bergsland, Niels
    Horakova, Dana
    Dwyer, Michael G.
    Uher, Tomas
    Vaneckova, Manuela
    Tyblova, Michaela
    Seidl, Zdenek
    Krasensky, Jan
    Havrdova, Eva
    Zivadinov, Robert
    NEUROIMAGE-CLINICAL, 2018, 17 : 444 - 451
  • [50] Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study
    Jacobsen, Cecilie
    Zivadinov, Robert
    Myhr, Kjell-Morten
    Dalaker, Turi O.
    Dalen, Ingvild
    Bergsland, Niels
    Farbu, Elisabeth
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (01)